You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫博泰生物-B(06990.HK):公司H股全流通獲聯交所授出上市批準
格隆匯 04-11 22:00

格隆匯4月11日丨科倫博泰生物-B(06990.HK)公告,公司已向聯交所申請批準("上市批準")25,421,196股H股(相當於根據轉換及上市將予轉換的內資股總數目)上市及準許買賣。董事會欣然宣佈,於2025年4月10日,聯交所已授出上市批準。

基於截至本公告日期的公司股本總數,轉換H股佔公司股本總數約11.19%,因此,公司H股佔公司股本總數的比例將因轉換及上市完成而由57.83%增加至69.02%,內資股將由40.13%減少至28.94%,而非上市外資股將維持於2.04%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account